Episode 5: Victor Olmos, Kendall Capital Partners

On Episode 5 of the Aayaam 360 Podcast, I speak with Victor Olmos at Kendall Capital Partners. The firm is named after Kendall Square, the ‘most innovative square mile on the planet.’ Its Founders are MIT Alumni, and other General Partners include Prof. Bob Langer and Prof. George Church, both influential figures in the industry.

Kendall Capital Partners invests in several disease areas and modalities, including Cell & Gene Therapies, Next-Gen Immunotherapies, Advanced Drug Delivery, and AI, Computational Biology & Scalable Infrastructure. The firm’s investments include EpiBone, a clinical-stage biotech company developing AI-designed, 3D-fabricated living bone and cartilage for skeletal reconstruction, and Centivax, a universal immunity company focused on creating vaccines and therapies that deliver universal protection against entire classes of diverse targets.

Check out the full episode.